Cancer has become a major public health problem that seriously threatens the health of our residents, and the national cancer statistics released by the National Cancer Center show that 7.5 people are diagnosed with cancer every minute in China. The "Healthy China 2030" Planning Outline issued by the State Council proposes that by 2030, the overall five-year survival rate of cancer will be increased by 15% by the strategic goal, and the standardized diagnosis and treatment of malignant tumors is an extremely important part of it.
Is there a combination therapy that significantly improves the conversion resection rate of non-resectable colorectal cancer liver metastasis? Is there still surgery value for recurrent ovarian cancer? In addition to traditional standard targeted drug therapy, is there a better combination of immunotherapy for liver cancer? Is laparoscopic treatment of early and even advanced gastric cancer safe and feasible? Is there a more rational and effective multidisciplinary treatment for advanced esophageal squamous cell carcinoma? This morning, at the 2021 Fudan Zhongshan Cancer Prevention and Control Center Annual Meeting, teams from the Department of General Surgery, Gynecologic Oncology, Hepatic Surgery, Thoracic Surgery and other teams from Zhongshan Hospital Affiliated to Fudan University shared the major breakthroughs made in cutting-edge research in their respective oncology fields.
Photo: Academician Fan Jia's speech Courtesy of the interviewee (the same below)
Fan Jia, academician of the Chinese Academy of Sciences, president of Zhongshan Hospital Affiliated to Fudan University, and director of Fudan Zhongshan Cancer Prevention and Control Center, said that China's tumor prevention and treatment cause has made great progress in the past few years after several generations of active exploration and unremitting efforts. Zhongshan Hospital has long been committed to the cause of comprehensive cancer prevention and treatment, in recent years, with the improvement of the overall comprehensive treatment demand for tumors, the hospital has established a cancer prevention and treatment center to comprehensively improve the level of comprehensive diagnosis and treatment of tumors. With the completion of the third phase of Zhongshan Hospital and the planning of Shanghai International Medical Science and Technology Innovation Center, it will continue to make breakthroughs in medical quality, innovative research and talent training, continuously promote the high-quality development of the hospital, strive to create a national oncology medical center and a national medical center, and make unremitting efforts to build a world-class innovative and intelligent modern hospital.
Fudan Zhongshan Cancer Prevention and Treatment Center has 5 departments, which are steadily advancing in the fields of disease screening and prevention, clinical diagnosis and treatment, scientific research, basic medical transformation, and data and information. Relying on the Health Management Center, Endoscopy Center, Precision Medicine Center and various chronic disease treatment departments of Zhongshan Hospital, the center establishes the concept of scientific science and cancer prevention for healthy people; relies on multidisciplinary diagnosis and treatment mode to improve the quality of life and prolong the survival time, continuously improves the satisfaction of tumor patients, and extends the diagnosis and treatment model to the units of the medical federation alliance; is committed to the research of new anti-tumor drugs and new technologies, continuously creates and improves clinical evidence, and fills in and updates the guidelines in related fields. Establish an "innovation transformation laboratory" based on pathology and laboratory disciplines and multi-omics biotechnology, create and invent new products with clinical transformation significance through continuous exploration of tumor mechanisms, rely on the hospital big data platform to realize the whole process of tumor data management, and gradually realize the intelligent decision-making assistance system, including the establishment of a special disease database and a special disease follow-up platform.
Pictured: At the meeting, the team of Academician Fan Jia of The Department of Liver Surgery, the team of Professor Sun Yihong and Professor Xu Jianmin of the Department of General Surgery, the team of Professor Zang Rongyu of the Department of Gynecology oncology, and the team of Chief Physician Tan Lijie of the Department of Thoracic Surgery were awarded the "Outstanding Research Contribution Award"; the team of Professor Zhou Jian of the Department of Liver Surgery, the team of Professor Shi Hongcheng of the Department of Nuclear Medicine and the team of Chief Physician Liu Tianshu of the Department of Oncology won the Excellent Team Award
According to Liu Tianshu, Secretary General of Fudan Zhongshan Cancer Prevention and Treatment Center and Director of the Department of Oncology of Zhongshan Hospital Affiliated to Fudan University, in the future, Fudan Zhongshan Cancer Prevention and Control Center will carry out clinical research, collaborative innovation, academic exchanges, talent training, and the promotion and application of achievement transformation from the comprehensive management mode of prevention, early diagnosis, multidisciplinary diagnosis and treatment to palliative care. Carry out high-quality clinical research on cancer, focus on clinical research design of tumors, directly hit the pain points and difficulties of clinical scientific research, and rely on the opportunity of the construction of the National Cancer Medical Center to become an industry benchmark that leads the development direction of oncology disciplines and integrates tumor prevention and treatment.
Pictured: Academician Fan Jia's team won the "Climbing The Peak of Science Award"
In the academician forum session, Academician Jiang Hualiang, Academician Dong Chen and Academician Fan Jia made keynote speeches on "Drug Development Based on Artificial Intelligence", "Immunotherapy Innovation - From Basic to Clinical Transformation", and "The Growth Path of Doctors and Scientists". During the meeting, the Zhongshan Cancer Prevention and Control Alliance and the Zhongshan Cancer Medical Association Forum were also held to discuss in depth the characteristics and countermeasures of tumor prevention and treatment in different regions. Fudan Zhongshan Cancer Prevention and Treatment Center actively responds to the national graded diagnosis and treatment and regional cancer center policies, and continues to carry out the construction of Zhongshan Cancer Medical Association and Fudan Zhongshan "Belt and Road" Cancer Prevention and Control Alliance.
Xinmin Evening News reporter Zuo Yan correspondent Jin Xiaolu